Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Input metadata referenced "Encompass Health Corp," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Quarterly Report).
Reporting Period: Three months ended March 31, 2001.
Business Overview: HealthSouth provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of March 31, 2001, the company operated approximately 2,018 locations across 50 states and several international markets.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Revenues | $1,090,462,000 | $1,021,335,000 |
| Net Income | $75,311,000 | $65,326,000 |
| Net Income Per Share (Diluted) | $0.19 | $0.17 |
| Operating Cash Flow | $80,196,000 | $77,052,000 |
| Working Capital | $1,201,934,000 | $1,048,204,000 (Dec 31, 2000) |
| Total Debt (Long-term + Current) | $3,253,694,000 | $3,211,829,000 (Dec 31, 2000) |
| Cash and Cash Equivalents | $181,677,000 | $180,317,000 (Dec 31, 2000) |
| Effective Tax Rate | 39.5% | 39.5% |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased by $69.1 million (6.8%) compared to Q1 2000, driven primarily by increased patient volume. Same-store revenues grew 5.2%, while new store revenues contributed $23.9 million.
- Profitability: Net income increased by $10.0 million (15.3%). Income before taxes rose to $149.5 million from $133.7 million.
- Expense Management: Operating expenses as a percentage of revenue improved slightly to 67.5% from 67.9%. Corporate general and administrative expenses decreased by $1.4 million.
- Interest Expense: Interest expense increased by $9.9 million (20%) to $59.4 million, primarily due to higher effective interest rates and new debt issuances.
- Debt Structure: The company issued $375 million in 8.5% Senior Notes in February 2001 to pay down credit facility indebtedness. Variable rate debt decreased from $1.655 billion to $1.354 billion.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Capital Expenditures: Management anticipates spending approximately $100 million to $150 million on maintenance/expansion and $200 million to $250 million on development activities over the next twelve months.
- Liquidity: The company believes existing cash, operating cash flow, and credit facilities are sufficient to meet requirements for the next 12 months.
- Recent Transaction: Subsequent to the quarter-end, the company closed on the sale of substantially all occupational medicine centers, with proceeds intended for debt retirement.
Risks and Contingencies
- Legal Proceedings: The company is defending against consolidated securities class action lawsuits alleging misrepresentations regarding financial condition and the impact of the Balanced Budget Act of 1997. The court denied the company's motion to dismiss in March 2001. Management believes the claims are without merit but cannot predict the outcome or potential loss magnitude.
- Reimbursement Risk: A significant portion of revenue comes from governmental payors (Medicare/Medicaid). Changes in reimbursement policies or rates could adversely affect future results.
- Interest Rate Risk: Approximately $1.354 billion of debt is subject to variable rates. The company utilizes interest rate swaps to hedge $655 million of this exposure. A hypothetical 1% increase in interest rates could reduce annual pre-tax earnings by approximately $13.5 million.
Investor Verification Checklist
- Verify the status and potential financial impact of the consolidated securities class action litigation (In re HealthSouth Corporation Securities Litigation).
- Monitor changes in Medicare and Medicaid reimbursement rates and their effect on the 30.5% of revenue derived from Medicare.
- Review the utilization of proceeds from the post-quarter sale of occupational medicine centers for debt reduction.
- Assess the impact of rising interest rates on the remaining variable-rate debt not covered by interest rate swaps.
- Confirm the execution of the planned $300 million to $400 million in capital expenditures for facility expansion and development.